Epoprostenol Injection, Powder, Lyophilized, For Solution
Product Images NDC 62756-059

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Epoprostenol (NDC 62756-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-epoprostenol-carton-1 (Spl Epoprostenol Carton 1)

This is a description of a medical product called Epoprostenol for Injection. The product is in a single-dose vial and is used for intravenous infusion only. It is a sterile, lyophilized product containing epoprostenol sodium, sucrose, glycine, and sodium hydroxide. The recommended storage condition is at room temperature between 20-25°C (68-77°F). The medication must be protected from light, and unused portions should be discarded. The manufacturer of the product is Sun Pharmaceutical Industries, Inc., and it is distributed in Cranbury, NJ. Dosage instructions and full prescribing information for dilution and storage stability of solutions are also available.*

FDA Label Image

Spl-epoprostenol-carton-2 (Spl Epoprostenol Carton 2)

This is a description of a medication called Epoprostenol for Injection. It is a sterile, lyophilized product used for intravenous infusion only with a dosage of 1.5 mg (1,500,000 ng). The product contains epoprostenol, 100 mg sucrose, 5 mg dycine, and sodium hyaroxids to adjust pH. Proper instructions for storage are given. The product is manufactured and distributed by Sun Pharmaceutical Industries, Inc. Full prescribing information should be consulted for more specific dosage and dilution instructions.*

FDA Label Image

Spl-epoprostenol-formula (Spl Epoprostenol Formula)

This text provides a formula to calculate the infusion rate in mL/hr based on the dose in ng/kg/min, the weight in kg and a conversion factor of 60 min/hr. It also mentions the calculation of the final concentration in ng/mL, but does not provide a formula or explanation for it.*

FDA Label Image

Spl-epoprostenol-structure (Spl Epoprostenol Structure)

FDA Label Image

Spl-epoprostenol-vial-1 (Spl Epoprostenol Vial 1)

This text appears to be instructions for reconstituting and administering a medication called Epoprostenol. The medication comes in a single-dose vial and must be diluted to a specific concentration before use. The reconstituted medication should be protected from light and stored at room temperature. Unused portions should be discarded. The text also includes information about the medication's NDC number, storage temperature, and a batch number.*

FDA Label Image

Spl-epoprostenol-vial-2 (Spl Epoprostenol Vial 2)

This is a description of a medication called Epoprostenol for Injection manufactured by Sun Pharmaceutical Industries. The medication comes in a single-dose vial containing 1.5mg of the active ingredient and is intended for intravenous infusion only. After the correct dose is drawn from the vial, it must be diluted to the final concentration before administration. Any unused portion of the product must be discarded. The medication should be stored at 20° to 25°C (68° to 77°F) and protected from light. Batch number and expiration date are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.